Kim, Ho Cheol
Kim, Tae Hoon
Kim, Ye-Jee
Rhee, Chin Kook
Oh, Yeon-Mok http://orcid.org/0000-0003-0116-4683
Funding for this research was provided by:
Ministry of Health and Welfare, Republic of Korea (HC16C-2254-010017)
Article History
Received: 11 February 2019
Accepted: 23 April 2019
First Online: 6 May 2019
Ethics approval and consent to participate
: The study protocol was approved by the Institutional Review Board of Asan Medical Center (approval number 2016–1028) and written informed consent was waived due to the retrospective nature of the study.
: Not applicable.
: YM Oh has received consulting/lecture fees from GSK, MSD, AstraZeneca, Novartis, and Boehringer-Ingelheim. CK Rhee has received consulting/lecture fees from MSD, AstraZeneca, Novartis, Takeda, Mundipharma, Boehringer-Ingelheim, Teva, and Bayer. Other authors have no financial or other potential conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.